
Cofik S 250mg/125mg Injection
Marketer
Sherwell Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cofik S 250mg/125mg Injection
Inficomb 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly as directed by your physician. Complete the prescribed treatment regimen; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, dyspnea). Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential drowsiness. While usually non-impairing, refrain from driving if experiencing drowsiness or dizziness. Ensure adequate rest, a balanced diet, and sufficient hydration to facilitate recovery. Your physician may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Cofik S 250mg/125mg Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Cofik S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cofik S 250mg/125mg Injection:
Administering this medication will be handled by your physician or their nursing staff; self-medication is strictly prohibited.
Common Side effects of Cofik S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cofik S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cofik S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cofik S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent use of Cofik S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Administering Cofik S 250mg/125mg Injection during pregnancy is typically regarded as safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Administering Cofik S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cofik S 250mg/125mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from driving while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cofik S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Cofik S 250mg/125mg Injection to patients with severe hepatic impairment requires careful consideration and potential dosage modification. Individuals with mild to moderate liver disease, however, do not typically necessitate dosage changes for this injection. Physician consultation is advised.
What if you forget to take Cofik S 250mg/125mg Injection :
Should you inadvertently skip a dose of Cofik S 250mg/125mg Injection, seek medical advice.
Facts to Know About Cofik S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
